CHRISTOPHER ANDERSON: Open Payments
NPI 1144817677 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 12 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $162 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: FARXIGA, LEQVIO, REPATHA, ELIQUIS, CAMZYOS, VERQUVO, JARDIANCE.
Industry payments across VA — which companies pay providers there.
